Non-animal testing is key to next phase of pharma growth
India's pharma sector should expand regulated non-animal testing to improve drug discovery, safety prediction, and global competitiveness.
- Non-animal testing methods can improve prediction of human drug response and can speed up drug development in India.
India’s pharmaceutical sector needs a stronger shift towards non-animal testing methods for drug development. The Hindu says organoids, organ-on-chip systems, advanced computation, and artificial intelligence can improve prediction of human outcomes, reduce development time, and support safer decision-making in drug discovery.
UPSC can frame the topic around biotechnology regulation, drug-development efficiency, and the ethical and scientific limits of animal testing. A strong answer should link innovation in organoids and organ-on-chip systems with regulatory validation, safety, and India’s aspiration to become a drug-discovery hub.
Related dispatches
